Analyses of phagocytosis of the tumor cells by macrophage revealed that afatinib and the anti‐CD47 antibody treatment each alone enhanced phagocytosis and that a stronger effect on phagocytosis was observed upon combined treatment with both reagents (Figure 6I,J and Figure S6D, Supporting Information, right table). The gene discussed is CD47; the disease is neoplasm.